We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 2.73% | 9.40 | 9.00 | 9.80 | 9.40 | 8.91 | 9.15 | 322,579 | 16:27:55 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.29 | 87.22M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/8/2017 15:43 | Not running away tosh .. another invention however you can explain "freebies with an average " and "instruments" while your here | inanaco | |
22/8/2017 15:41 | I invent stuff..... hahaha... coming from the king of lies thats outrageously funny. The man that spends all day making stuff up and then running away from what he's said, has the audacity to accuse someone else of making stuff up, brilliant. | tosh123 | |
22/8/2017 15:33 | lozan .... I think you have missed out something ... like Interesting discussions that would actually prompt me to engage ... Sp going Up ... your zero holding is stagnant | inanaco | |
22/8/2017 15:26 | TEA LEAF - Whereas there is always a possibility - however SLIGHT, that YOUR former 'flock' on the now ELSIE'S s Central - might "wish" to converse with me... or ...I with them ... remains very remote. BUT What is abundantly CLEAR is = They want NOWT to do with YOU any more. | the real lozan | |
22/8/2017 15:17 | lozan ... if you wish to spend your days discussing every trade with C7 .. be my guest as for profit and loss .... you have no shares .. = zero balance sheet | inanaco | |
22/8/2017 15:13 | Many, will no doubt - be of a mind - that this week-long, and increasing 'Hissy-fit' by der TEA LEAF, cannot simply be as a result of Elsie's exposing HIS proven past DECEPTIONS and LIES... or the FACT that Elsie @ ELSIE S Central = HAS stolen HIS thunder.... or HE is STILL sitting on £££ HIS 'deep-rooted' problems DO appear to be of a 'psychological nature' / illusions of grandure, perhaps ??? . Still - never mind eh must prepare for tonights BBQ ... bit hot yet though... just slipping past 46 C in the direct sun ...33.1 in the shade under the auvent der TEA LEAF helped pay for. | the real lozan | |
22/8/2017 15:03 | Boom, Therein lies the problem with taking old posts out of context. When I posted that (2 years ago) it was NOT to try and accurately value what SCLP might be worth but to highlight what it cannot be worth. Even being overly optimistic you can't get £6 let alone £10, £12 or £20 as has been banded around in the past, I stress, IN THE PAST. As regards you 2nd point, you are right, I had missed the fact that SCIB1 validates SCIB2. However, even with some sort of validation, it still needs to go through its own phase I/II/III trials and these will require funding. But thanks for highlighting that omission on my part, it is what discussion boards are all about! | gazza | |
22/8/2017 15:02 | just jog on and leave the adults to talk. they will have a far more informative BB without all your LIES. all you do is try to claw back some form of credibility ... and it aint working so just clear off you loser. | tosh123 | |
22/8/2017 14:58 | Inanaco 10811 You said "Posts devoid of content, merit, thought, intelligence or facts." Finally, we have found something we have in common. Are you my long lost cousin? | gazza | |
22/8/2017 14:57 | " Everyone " ? please quantify and PROVE " everyone " . Or is this just another of Ineptico's delusional LIES ? People are selling, so your statement that " everyone " agrees with you is absolute garbage, but hey ho, whats new in that. and NO, i dont think the potential for gain or loss from this point is the same, the most basic of mathematics tells you that you idiot.... once you've moved onto numbers, this will become apparent. It all depends on what your entry price is..How can a share plunging to 0p mean the same loss to someone that bought at 45p as it does to someone that bought at 6p ? Its very basic stuff you cretin. and for the profit, the exact same rules apply... so once again, you're talking absolute rubbish ! you really must learn to keep your mouth shut you LOSER. | tosh123 | |
22/8/2017 14:50 | by the way boom the "Ouch" was for using "unknown" in context | inanaco | |
22/8/2017 14:45 | who is bashing Gazza ? Loz .... | inanaco | |
22/8/2017 14:43 | Gazza - 25 Apr 2017 - 19:34:15 - 9069 of 10813 Using immunology to fight cancer. - SCLP Tosh, ok. I can't quite reconcile your stance of holding tight whilst calling others doing the same "cretins". Anyone with a holding, large or small, hold in expectation of improving their situation from hereon in. The potential for gain or loss from this point is the same whether you are sitting on a profit or a loss don't you think? -------------------- so tosh everyone seems to agree with me ...... even Gazza LOL | inanaco | |
22/8/2017 14:39 | An afternoon spent Gazza-bashing, simply because Gash told you to 'include him OUT' of YOUR garbage... and that isn't /doesn't " disrupt the BB " ...GUFFAW . Or are YOU taking exception to the 'mentioned SELLING showing-up' ??? | the real lozan | |
22/8/2017 14:25 | yet again .... Tosh and Loz attempt to disrupt the BB | inanaco | |
22/8/2017 14:24 | Boom read my post again... Your on the combo market ... I am valuing the asset which was designed as an adjuvant treatment. however its synergy with PD1 "could" prove to be its first route to commercial success but as an asset it has 2 routes to market and you have to value both and you can based on the current market expenditure of hospitals .... because patients don't become end stage first .. | inanaco | |
22/8/2017 14:17 | More and more desperate to try and salvage any form of credibility, he is now trawling back through posts from over a year ago hahahaha, what a dimwit, and how desperate must the village idiot be. Why don't you just accept the fact that you have LOST, and shown yourself to be a LIAR - CHEAT - LOSER - DECEITFUL, and just jog on ? Nothing you say is anything other than pure LIES as you have PROVEN. So just take yourself and that other bloke "Nana", off to somewhere with nice cushioned walls and a tight fitting jacket, and let the nice people try to mend everything that is broken. If you're lucky, the nice men might even teach you how to read and write, and maybe even do some sums for you. | tosh123 | |
22/8/2017 14:17 | Ouch yourself I'm not saying there isn't value - of course there's tremendous value. Seriously life changing value for some. To achieve an accurate valuation in the combination setting you will need to know the following:- 1) Which anti PD-1 will it be combined with? 2) Will it be approved by FDA as a 1st line treatment or 2nd line? Will it be given to every patient treated with that PD-1 or just those who fail treatment on 1st round? 3) Will there be any restrictions/thresho | bermudashorts | |
22/8/2017 14:12 | Boom I suggest you find the negative ... rather than using the words "unkown" as your sending a very confusing message, I have discussed this on the other BB, Trials give us transparency so any negatives can be found, as such the science is commercial so can be put into context .... otherwise no point investing | inanaco | |
22/8/2017 14:05 | Ouch Boom It's just not possible at this stage to predict with any degree of accuracy the potential market share for SCIB1, even assuming successful trials. There are simply far too many unknowns. So if you don't know the market, and even if you did, you can't predict market share how can any one of us possibly work out a meaningful value? We already have a "gold standard trial" as the scib1 adjuvant is before PD1 ..... if you only value the PD1 market it gives value to the adjuvant market regardless of what is approved in the adjuvant setting with PD1 etc, SCIB1 beats it hands down on toxicity i really cannot see how you can not place value to the asset | inanaco | |
22/8/2017 14:00 | If you read Panumre's research note for Scancell, you'll see that the only valuation method they felt was appropriate was comparison of the value of other deals within the sector. It's just not possible at this stage to predict with any degree of accuracy the potential market share for SCIB1, even assuming successful trials. There are simply far too many unknowns. So if you don't know the market, and even if you did, you can't predict market share how can any one of us possibly work out a meaningful value? Gazza, would also just like to take issue with your comment on SCIB2. Perhaps I'm misunderstanding the point you're trying to make. If SCIB1 is commercialised and becomes revenue generating, it actually goes some way towards validating SCIB2. So the risk/chance of failure doesn't increase just because SCIB1 revenue is being used to fund it - quite the opposite. Moreover, if Scancell ever get to that stage, we will be discussing the value of other SCIBs - commercialise one product and the whole platform becomes less risky and more valuable. | bermudashorts | |
22/8/2017 13:53 | so what we are looking for is One post that back Tosh and Lozan mmmmmmmmmmmmmmm !! | inanaco |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions